TGFB3 and breast carcinoma: Ghella et al. [29] studied 153 invasive breast cancer samples and found that upregulated TGF-β3 expression was inversely related to OS in patients with breast cancer, especially in patients with node metastases, suggesting that TGF-β3 may be used for predicting poor prognosis in breast cancer patients.